Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Pathology
|
August 15, 2008
Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials
V F Viprey, M A Lastowska, M V Corrias, et al.
British Journal of Cancer
|
November 20, 1998
Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma
Y F Zhang, S Jeffery, S A Burchill, et al.
Medical and Pediatric Oncology
|
July 24, 2001
Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma
S A Burchill, S E Kinsey, S Picton, et al.
International Journal of Cancer
|
June 30, 1998
Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20
D K Wyld, P Selby, T J Perren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year
S A Burchill, I J Lewis, K R Abrams, et al.
British Journal of Cancer
|
April 17, 2003
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
R D Riley, K R Abrams, A J Sutton, et al.
British Journal of Cancer
|
April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
K Beiske, S A Burchill, I Y Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2002
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family
R D Riley, S A Burchill, K R Abrams, et al.
Health Technology Assessment (Winchester, England)
|
March 14, 2003
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
R D Riley, S A Burchill, K R Abrams, et al.
Oncogene
|
May 30, 2007
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data
M Łastowska, V Viprey, M Santibanez-Koref, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
The Journal of Pathology
|
August 15, 2008
Minimal disease monitoring by QRT-PCR: guidelines for identification and systematic validation of molecular markers prior to evaluation in prospective clinical trials
V F Viprey, M A Lastowska, M V Corrias, et al.
British Journal of Cancer
|
November 20, 1998
Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma
Y F Zhang, S Jeffery, S A Burchill, et al.
Medical and Pediatric Oncology
|
July 24, 2001
Minimal residual disease at the time of peripheral blood stem cell harvest in patients with advanced neuroblastoma
S A Burchill, S E Kinsey, S Picton, et al.
International Journal of Cancer
|
June 30, 1998
Detection of colorectal cancer cells in peripheral blood by reverse-transcriptase polymerase chain reaction for cytokeratin 20
D K Wyld, P Selby, T J Perren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2001
Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year
S A Burchill, I J Lewis, K R Abrams, et al.
British Journal of Cancer
|
April 17, 2003
Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future
R D Riley, K R Abrams, A J Sutton, et al.
British Journal of Cancer
|
April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task Force
K Beiske, S A Burchill, I Y Cheung, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 31, 2002
A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family
R D Riley, S A Burchill, K R Abrams, et al.
Health Technology Assessment (Winchester, England)
|
March 14, 2003
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
R D Riley, S A Burchill, K R Abrams, et al.
Oncogene
|
May 30, 2007
Identification of candidate genes involved in neuroblastoma progression by combining genomic and expression microarrays with survival data
M Łastowska, V Viprey, M Santibanez-Koref, et al.
Page
of 5